Global Artificial Internal Organs Market Growth 2025-2031

The global Artificial Internal Organs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Artificial internal organs, also known as artificial organs or medical implants, are synthetic devices or structures designed to replace or augment the function of natural organs or tissues in the human body. These artificial organs are typically used in medical procedures to treat or manage various health conditions and organ failures. They serve as a vital means of prolonging and improving the quality of life for many individuals.

These artificial organs and devices are designed to improve and extend the lives of individuals affected by organ failure, chronic diseases, or traumatic injuries. They are developed through a combination of engineering, materials science, and medical expertise and require careful monitoring and maintenance to ensure their effectiveness and the well-being of patients. The field of artificial organs continues to advance, with ongoing research and development aimed at improving the performance and availability of these life-saving technologies.

United States market for Artificial Internal Organs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Artificial Internal Organs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Artificial Internal Organs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Artificial Internal Organs players cover Abbott, Medtronic, Fresenius Medical Care, Abiomed, SynCardia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Artificial Internal Organs Industry Forecast” looks at past sales and reviews total world Artificial Internal Organs sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Internal Organs sales for 2025 through 2031. With Artificial Internal Organs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Internal Organs industry.

This Insight Report provides a comprehensive analysis of the global Artificial Internal Organs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Internal Organs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Internal Organs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Internal Organs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Internal Organs.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Internal Organs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Artificial Kidney
Artificial Heart
Artificial Lung
Artificial Liver
Artificial Pancreas
Others

Segmentation by Application:
Commercialize
Clinical Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Medtronic
Fresenius Medical Care
Abiomed
SynCardia
Carmat
Baxter
Toray Medical
Getinge
LivaNova
Terumo

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artificial Internal Organs market?

What factors are driving Artificial Internal Organs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artificial Internal Organs market opportunities vary by end market size?

How does Artificial Internal Organs break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.